Verition Fund Management
PTCT icon

Verition Fund Management’s PTC Therapeutics PTCT Stock Holding History

Verition Fund Management’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-11,300
Closed -$543K – 963
2019
Q4 		$543K Hold
11,300
– – 0.01% 641
2019
Q3 		$382K Buy
+11,300
New +$492K 0.01% 728

Other funds holding PTCT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Verition Fund Management's PTCT Position: Q1 2026 in Review

Verition Fund Management sold out of PTC Therapeutics (PTCT) in Q1 2026, closing a stake of 20,200 shares — an estimated $1.53M sold.

Verition Fund Management first reported a position in PTCT in Q1 2018 and held it in 19 quarters. The position peaked at $5.64M in Q2 2025. 350 funds tracked by Wall St. Rank hold PTCT as of Q1 2026.

  • Verition Fund Management reported no remaining PTC Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Verition Fund Management sold 20,200 PTC Therapeutics shares in Q1 2026, an estimated $1.53M.
  • Verition Fund Management first reported a position in PTC Therapeutics in Q1 2018 and held it in 19 quarters.
  • Verition Fund Management's PTC Therapeutics position peaked at $5.64M in Q2 2025.
  • 350 funds tracked by Wall St. Rank held PTC Therapeutics as of Q1 2026.

Based on Verition Fund Management's 13F filing for Q1 2026, filed 15 May 2026.